These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 6128384)

  • 1. Effect of cyclodextrins on the acid hydrolysis of digoxin.
    Uekama K; Fujinaga T; Hirayama F; Otagiri M; Kurono Y; Ikeda K
    J Pharm Pharmacol; 1982 Oct; 34(10):627-30. PubMed ID: 6128384
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced bioavailability of digoxin by gamma-cyclodextrin complexation.
    Uekama K; Fujinaga T; Otagiri M; Seo H; Tsuruoka M
    J Pharmacobiodyn; 1981 Sep; 4(9):735-7. PubMed ID: 7334457
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Digoxin degradation in acidic dissolution medium.
    Sonobe T; Hasumi S; Yoshino T; Kobayashi Y; Kawata H; Nagai T
    J Pharm Sci; 1980 Apr; 69(4):410-3. PubMed ID: 7373535
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epimerization and racemization of some chiral drugs in the presence of cyclodextrin and liposomes.
    Aso Y; Yoshioka S; Takeda Y
    Chem Pharm Bull (Tokyo); 1989 Oct; 37(10):2786-9. PubMed ID: 2611938
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Some pharmaceutical properties of 3-hydroxypropyl- and 2,3-dihydroxypropyl-beta-cyclodextrins and their solubilizing and stabilizing abilities.
    Yoshida A; Yamamoto M; Irie T; Hirayama F; Uekama K
    Chem Pharm Bull (Tokyo); 1989 Apr; 37(4):1059-63. PubMed ID: 2766408
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stabilizing and solubilizing effects of sulfobutyl ether beta-cyclodextrin on prostaglandin E1 analogue.
    Uekama K; Hieda Y; Hirayama F; Arima H; Sudoh M; Yagi A; Terashima H
    Pharm Res; 2001 Nov; 18(11):1578-85. PubMed ID: 11758766
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kinetics of digoxin stability in aqueous solution.
    Sternson LA; Shaffer RD
    J Pharm Sci; 1978 Mar; 67(3):327-30. PubMed ID: 25324
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Enhanced bioavailability of digoxin by gamma-cyclodextrin complexation: evaluation for sublingual and oral administrations in humans].
    Seo H; Uekama K
    Yakugaku Zasshi; 1989 Oct; 109(10):778-82. PubMed ID: 2621567
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improvement of oral bioavailability of prednisolone by beta-cyclodextrin complexation in humans.
    Uekama K; Otagiri M; Uemura Y; Fujinaga T; Arimori K; Matsuo N; Tasaki K; Sugii A
    J Pharmacobiodyn; 1983 Feb; 6(2):124-7. PubMed ID: 6864436
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inclusion complexation of artemisinin with alpha-, beta-, and gamma-cyclodextrins.
    Wong JW; Yuen KH
    Drug Dev Ind Pharm; 2003 Oct; 29(9):1035-44. PubMed ID: 14606667
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Study of the interaction of clobazam with cyclodextrins in solution and in the solid state.
    Nakai Y; el-Said Aboutaleb A; Yamamoto K; Saleh SI; Ahmed MO
    Chem Pharm Bull (Tokyo); 1990 Mar; 38(3):728-32. PubMed ID: 2347015
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Utility of 2-hydroxypropyl-beta-cyclodextrin in an intramuscular injectable preparation of nimodipine.
    Yoshida A; Yamamoto M; Itoh T; Irie T; Hirayama F; Uekama K
    Chem Pharm Bull (Tokyo); 1990 Jan; 38(1):176-9. PubMed ID: 2337940
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protection against the photosensitized skin irritancy of chlorpromazine by cyclodextrin complexation.
    Irie T; Uekama K
    J Pharmacobiodyn; 1985 Sep; 8(9):788-91. PubMed ID: 4087139
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protective effects of cyclodextrins on drug-induced hemolysis in vitro.
    Uekama K; Irie T; Sunada M; Otagiri M; Tsubaki K
    J Pharmacobiodyn; 1981 Feb; 4(2):142-4. PubMed ID: 7277200
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improvement of the oral bioavailability of digitalis glycosides by cyclodextrin complexation.
    Uekama K; Fujinaga T; Hirayama F; Otagiri M; Yamasaki M; Seo H; Hashimoto T; Tsuruoka M
    J Pharm Sci; 1983 Nov; 72(11):1338-41. PubMed ID: 6644599
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heptakis(2,6-di-O-methyl)-beta-cyclodextrin complexation with the antitumor agent chlorambucil.
    Green AR; Guillory JK
    J Pharm Sci; 1989 May; 78(5):427-31. PubMed ID: 2746481
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The formation of an inclusion complex between a metabolite of ginsenoside, compound K and γ-cyclodextrin and its dissolution characteristics.
    Igami K; Ozawa M; Inoue S; Iohara D; Miyazaki T; Shinoda M; Anraku M; Hirayama F; Uekama K
    J Pharm Pharmacol; 2016 May; 68(5):646-54. PubMed ID: 26255976
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclodextrin-induced hemolysis and shape changes of human erythrocytes in vitro.
    Irie T; Otagiri M; Sunada M; Uekama K; Ohtani Y; Yamada Y; Sugiyama Y
    J Pharmacobiodyn; 1982 Sep; 5(9):741-4. PubMed ID: 7153847
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of beta- and gamma-cyclodextrins on the pharmacokinetic behavior of prednisolone after intravenous and intramuscular administrations to rabbits.
    Arimori K; Uekama K
    J Pharmacobiodyn; 1987 Aug; 10(8):390-5. PubMed ID: 3694434
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improvement in the percutaneous absorption of beclomethasone dipropionate by gamma-cyclodextrin complexation.
    Uekama K; Otagiri M; Sakai A; Irie T; Matsuo N; Matsuoka Y
    J Pharm Pharmacol; 1985 Aug; 37(8):532-5. PubMed ID: 2864411
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.